Clinical Trial Update: Drug-Drug Interaction Study Between Hydronidone and Entecavir, Tenofovir Disoproxil Fumarate, Tenofovir Alafenamide, and Tenofovir Amibufenamide [Phase 1]

View source ↗

Summary

Phase 1 drug–drug interaction study investigating Hydronidone with entecavir and several tenofovir prodrugs in chronic hepatitis B with liver fibrosis; the tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Liver Fibrosis

Drugs mentioned

• Baraclude (entecavir)
• Hydronidone (Hydronidone)
• Tenofovir Amibufenamide (tenofovir amibufenamide)
• Vemlidy (tenofovir alafenamide)
• Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: Beijing Continent Pharmaceutical Co, Ltd. | Conditions: Chronic Hepatitis B Liver Fibrosis, DDI (Drug-Drug Interaction) | Phase 1 | Status: NOT_YET_RECRUITING